微生态制剂在肠易激综合征中的临床应用及评价

被引：23

作者：

莫文辉

郭传勇

机构：

[1] 同济大学附属第十人民医院

来源：

世界临床药物 | 2008年 / 29卷 / 12期

关键词：

肠易激综合征; 肠道微生态; 微生态制剂;

D O I：

暂无

中图分类号：

R574.4 [肠道功能紊乱];

学科分类号：

100201 [内科学];

摘要：

肠易激综合征(IBS)是一组较为常见的、病因及发病机制未明的临床综合征,目前尚无特异性药物能用于缓解IBS患者的各种症状。近年来肠道菌群失调与IBS的关系,以及微生态制剂在IBS治疗中的应用逐渐引起人们的关注,本文简要综述微生态制剂与IBS的研究现状。

引用

页码：722 / 726

页数：5

共 18 条

[1]

Bacteria and irritable bowel syndrome: The evidence for small intestinal bacterial overgrowth [J].

Lee H.-R. ;

Pimentel M. .

Current Gastroenterology Reports, 2006, 8 (4) :305-311

[2]

The use of Lactobacillus GG in irritable bowel syndrome in children:: A double-blind randomized control trial [J].

Bausserman, M ;

Michail, S .

JOURNAL OF PEDIATRICS, 2005, 147 (02) :197-201

[3]

Is the prevalence of small bowel bacterial overgrowth in patients with irritable bowel syndrome increased? The question remains unanswered [J].

Draganov, P ;

Toskes, P .

DIGESTIVE DISEASES AND SCIENCES, 2005, 50 (08) :1461-1461

[4]

Probiotics in The Treatment of Irritable Bowel Syndrome.[J].Alfredo Saggioro.Journal of Clinical Gastroenterology.2004,

[5]

Gut flora in health and disease [J].

Guarner, F ;

Malagelada, JR .

LANCET, 2003, 361 (9356) :512-519

[6]

Probiotics, irritable bowel syndrome, and inflammatory bowel disease [J].

Martin H. Floch .

Current Treatment Options in Gastroenterology, 2003, 6 (4) :283-288

[7]

Antibiotics increase functional abdominal symptoms [J].

Maxwell, PR ;

Rink, E ;

Kumar, D ;

Mendall, MA .

AMERICAN JOURNAL OF GASTROENTEROLOGY, 2002, 97 (01) :104-108

[8]

Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome [J].

Pimentel, M ;

Chow, EJ ;

Lin, HC .

AMERICAN JOURNAL OF GASTROENTEROLOGY, 2000, 95 (12) :3503-3506

[9]

内科学.[M].王吉耀主编.人民卫生出版社.2005,

[10]

肠易激综合征与肠道微生态的研究现状分析 [J].

吴蓉 ;

陈淑洁 ;

姒健敏 .

国际消化病杂志, 2007, (05) :350-352+385

← 1 2 →